84 related articles for article (PubMed ID: 32650901)
1. Meta-analysis Examining the Usefulness of Angiotensin Receptor blockers for the Prevention of Aortic Root Dilation in Patients With the Marfan Syndrome.
Al-Abcha A; Saleh Y; Mujer M; Boumegouas M; Herzallah K; Charles L; Elkhatib L; Abdelkarim O; Kehdi M; Abela GS
Am J Cardiol; 2020 Aug; 128():101-106. PubMed ID: 32650901
[TBL] [Abstract][Full Text] [Related]
2. Drug-based cardiovascular prevention in patients with Marfan Syndrome: a systematic review.
Pavasini R; Sanguettoli F; Deserio MA; Bianchi N; Zanarelli L; Fabbri G; Tonet E; Passarini G; Serenelli M; Campo G
Minerva Cardiol Angiol; 2023 Dec; 71(6):611-621. PubMed ID: 36939732
[TBL] [Abstract][Full Text] [Related]
3. Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.
Lacro RV; Dietz HC; Wruck LM; Bradley TJ; Colan SD; Devereux RB; Klein GL; Li JS; Minich LL; Paridon SM; Pearson GD; Printz BF; Pyeritz RE; Radojewski E; Roman MJ; Saul JP; Stylianou MP; Mahony L;
Am Heart J; 2007 Oct; 154(4):624-31. PubMed ID: 17892982
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Rapid Aortic Root Dilation and Referral for Aortic Surgery in Marfan Syndrome.
Hoskoppal A; Menon S; Trachtenberg F; Burns KM; De Backer J; Gelb BD; Gleason M; James J; Lai WW; Liou A; Mahony L; Olson AK; Pyeritz RE; Sharkey AM; Stylianou M; Wechsler SB; Young L; Levine JC; Tierney ESS; Lacro RV; Bradley TJ;
Pediatr Cardiol; 2018 Oct; 39(7):1453-1461. PubMed ID: 29948025
[TBL] [Abstract][Full Text] [Related]
5. Atenolol versus losartan in children and young adults with Marfan's syndrome.
Lacro RV; Dietz HC; Sleeper LA; Yetman AT; Bradley TJ; Colan SD; Pearson GD; Selamet Tierney ES; Levine JC; Atz AM; Benson DW; Braverman AC; Chen S; De Backer J; Gelb BD; Grossfeld PD; Klein GL; Lai WW; Liou A; Loeys BL; Markham LW; Olson AK; Paridon SM; Pemberton VL; Pierpont ME; Pyeritz RE; Radojewski E; Roman MJ; Sharkey AM; Stylianou MP; Wechsler SB; Young LT; Mahony L;
N Engl J Med; 2014 Nov; 371(22):2061-71. PubMed ID: 25405392
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Strategies to Block Downstream Effectors of AT1R-Mediated Signalling to Prevent Aneurysm Formation in Marfan Syndrome.
Valdivia Callejon I; Buccioli L; Bastianen J; Schippers J; Verstraeten A; Luyckx I; Peeters S; Danser AHJ; Van Kimmenade RRJ; Meester J; Loeys B
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732244
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure-independent inhibition of Marfan aortic root widening by the angiotensin II receptor blocker valsartan.
Tehrani AY; White Z; Milad N; Esfandiarei M; Seidman MA; Bernatchez P
Physiol Rep; 2021 May; 9(10):e14877. PubMed ID: 34042309
[TBL] [Abstract][Full Text] [Related]
8. Losartan for Preventing Aortic Root Dilatation in Patients with Marfan Syndrome: A Meta-Analysis of Randomized Trials.
Elbadawi A; Omer MA; Elgendy IY; Abuzaid A; Mohamed AH; Rai D; Saad M; Mentias A; Rezq A; Kamal D; Khalife W; London B; Morsy M
Cardiol Ther; 2019 Dec; 8(2):365-372. PubMed ID: 31606871
[TBL] [Abstract][Full Text] [Related]
9. Echocardiographic methods, quality review, and measurement accuracy in a randomized multicenter clinical trial of Marfan syndrome.
Selamet Tierney ES; Levine JC; Chen S; Bradley TJ; Pearson GD; Colan SD; Sleeper LA; Campbell MJ; Cohen MS; De Backer J; Guey LT; Heydarian H; Lai WW; Lewin MB; Marcus E; Mart CR; Pignatelli RH; Printz BF; Sharkey AM; Shirali GS; Srivastava S; Lacro RV;
J Am Soc Echocardiogr; 2013 Jun; 26(6):657-66. PubMed ID: 23582510
[TBL] [Abstract][Full Text] [Related]
10. β-Blockers and angiotensin converting enzyme inhibitors: comparison of effects on aortic growth in pediatric patients with Marfan syndrome.
Phomakay V; Huett WG; Gossett JM; Tang X; Bornemeier RA; Collins RT
J Pediatr; 2014 Nov; 165(5):951-5. PubMed ID: 25109242
[TBL] [Abstract][Full Text] [Related]
11. An exploration of alternative therapeutic targets for aortic disease in Marfan syndrome.
Van Den Heuvel LJF; Peeters S; Meester JAN; Coucke PJ; Loeys BL
Drug Discov Today; 2024 May; 29(7):104023. PubMed ID: 38750929
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II Receptor Blockers Are Associated With Reduced Valvular Fibrosis in Women With Aortic Stenosis.
Carter-Storch R; Le Nezet E; Ali M; Powers A; Haujir A; Demers K; Couture C; Dumont É; Trahan S; Pagé S; Dagenais F; Pibarot P; Dahl JS; Clavel MA
Can J Cardiol; 2024 Mar; ():. PubMed ID: 38518892
[TBL] [Abstract][Full Text] [Related]
13. Graded Mobilization With Pacing Technique for Functional Mobility in a Preoperative Marfan Syndrome Case of Aortic Root Dilation: A Case Report.
Bhagwatkar SS; Yadav V; Ankar P; Arya N
Cureus; 2024 Feb; 16(2):e54591. PubMed ID: 38524030
[TBL] [Abstract][Full Text] [Related]
14. Unlocking Sex-Specific Therapies in Aortic Stenosis: A Leap Forward With Angiotensin II Receptor Blockers.
Hillier E; Luu J
Can J Cardiol; 2024 Apr; ():. PubMed ID: 38614313
[No Abstract] [Full Text] [Related]
15. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome.
Shores J; Berger KR; Murphy EA; Pyeritz RE
N Engl J Med; 1994 May; 330(19):1335-41. PubMed ID: 8152445
[TBL] [Abstract][Full Text] [Related]
16. Medical Therapies for Marfan Syndrome and Other Thoracic Aortic Dilatation in Adults: A Contemporary Review.
Kocyigit D; Griffin BP; Xu B
Am J Cardiovasc Drugs; 2021 Nov; 21(6):609-617. PubMed ID: 33748919
[TBL] [Abstract][Full Text] [Related]
17. Cardiogenetics: genetic testing in the diagnosis and management of patients with aortic disease.
Thakker PD; Braverman AC
Heart; 2021 Apr; 107(8):619-626. PubMed ID: 33334864
[TBL] [Abstract][Full Text] [Related]
18. Insights on the Pathogenesis of Aneurysm through the Study of Hereditary Aortopathies.
Creamer TJ; Bramel EE; MacFarlane EG
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33514025
[TBL] [Abstract][Full Text] [Related]
19. Comparability of different Z-score equations for aortic root dimensions in children with Marfan syndrome.
Rutten DWE; Aarts-Janssen IJH; Kempers MJE; Reimer AG; Udink Ten Cate FEA; Loeys BL; Slieker MG
Cardiol Young; 2021 Dec; 31(12):1962-1968. PubMed ID: 33843540
[TBL] [Abstract][Full Text] [Related]
20. The Role of Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi: A Meta-Analysis and Systematic Review.
Al-Abcha A; Herzallah K; Saleh Y; Mujer M; Abdelkarim O; Abdelnabi M; Almaghraby A; Abela GS
Am J Cardiovasc Drugs; 2021 Jul; 21(4):435-441. PubMed ID: 33354748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
